MPM Capital
Frank Neumann is an experienced leader in the biotechnology and pharmaceutical sectors, currently serving as an Entrepreneur Partner at MPM BioImpact since April 2024. Previously, Frank held the position of Chief Medical Officer and Board Member at Orna Therapeutics from October 2023 to April 2024. Frank also worked at Kite Pharma from February 2021 to May 2024 as SVP and Global Head of Clinical Development. Prior to this, Frank served as Chief Medical Officer at Verastem Oncology for a brief period in early 2021 and was VP and Head of Oncology Clinical Research at Bluebird Bio from July 2019 to January 2021.
This person is not in any teams
This person is not in any offices